Psoriatic arthritis treatment and management (Management of psoriatic arthritis)
The ongoing, specialist-led plan to control psoriatic arthritis, ease joint, skin and tendon symptoms and protect joints, using medicines, monitoring and support.
✓ Medically reviewed by a GMC-registered consultant · last reviewed September 2026 · next review September 2027 · how we review
In short
- Psoriatic arthritis management is an ongoing plan to control joint, tendon, skin and nail inflammation and protect joints, not a one-off treatment.
- The aim is to settle inflammation early, but treatment controls rather than cures PsA, and the plan often needs adjusting over time.
- Many medicines used (DMARDs, biologics, targeted tablets) need monitoring blood tests and carry some infection risk, which is part of the trade-off.
- Because PsA affects people differently, treatment is tailored to your main problems, and the skin and joints are often best managed together.
A plain-English summary. The detail — including risks and recovery — is below.
At a glance
A general guide. Your specialist will give you advice for your situation.
Can reduce joint pain, swelling and stiffness, and settle swollen fingers, toes and tendons
A particular medicine may not suit you because of liver, kidney, bowel or blood problems, or a current infection.
Disease-modifying medicines often take several weeks to work. An NSAID, a short steroid course or a local injection may help in the meantime. Early blood...
Regular review of joint and skin activity against a clear target.
Disease-modifying medicines often take several weeks to work. An NSAID, a short steroid course or a local...
Your team reviews early response in the joints, tendons and skin. The dose may be increased or another medicine...
Biologic and targeted treatments are judged at a defined time. If there has not been an adequate response...
Regular appointments check joint and skin activity, side effects and monitoring bloods, and adjust treatment over...
What is psoriatic arthritis management?
Psoriatic arthritis (PsA) is a long-term condition where the immune system causes inflammation in and around the joints. It is linked to the skin condition psoriasis, though not everyone with PsA has obvious skin problems. As well as joint pain and stiffness, it can cause swollen fingers or toes (dactylitis), pain where tendons join bone (enthesitis), nail changes and fatigue.
'Management' means the whole plan to keep PsA under control, not a single treatment. It usually combines medicines that calm inflammation, regular monitoring, and support with exercise, skin care, work and daily life. A rheumatologist usually leads this, often working with a dermatologist when the skin is also involved.
Care follows a 'treat to target' idea: control inflammation early and adjust treatment until symptoms are low or settled, to protect the joints and improve quality of life. Because PsA can affect joints, tendons, skin and nails differently in different people, treatment is tailored to which features are causing the most trouble.
It is important to be realistic. Treatment can control PsA well for many people, but it does not cure it, it does not work for everyone, and the plan often needs adjusting over time. Good management means working with your team and treating the condition as a whole, including the skin.
Types, options & approaches
There may be different ways to do this. The right approach depends on the clinical question and your circumstances.
Symptom relief versus disease control
| Painkillers/NSAIDs | DMARDs/biologics | |
|---|---|---|
| Eases pain | Yes, fairly quickly | Yes, more slowly |
| Changes the disease | No | Yes |
| Helps the skin too | No | Some do |
| Needs blood monitoring | Sometimes | Usually |
Painkillers ease symptoms but do not stop joint damage. Disease-modifying and biologic treatments change the disease, and some also help the skin, so treatment is tailored to your main problems.
Preparing for your treatment
- Bring a note of your symptoms: which joints are affected, any swollen fingers or toes, tendon pain, nail changes, skin psoriasis and fatigue.
- Bring all your medicines and supplements, and any allergies or past drug reactions.
- Have recent blood tests, X-rays or scans, and previous clinic letters available if you have them.
- Tell the team about other health conditions, especially infections, liver, kidney or bowel problems.
- Sort out vaccinations where you can, as some medicines mean avoiding live vaccines; flu and recommended COVID-19 vaccines are encouraged.
- Tell the team if you could be pregnant, are planning pregnancy or are breastfeeding, as this affects medicine choice.
- Think about which symptoms trouble you most, including skin and fatigue, and your goals for work and activity.
What happens
At a rheumatology appointment, the clinician asks about your joint, tendon, skin, nail and fatigue symptoms, examines you for swollen joints, dactylitis and enthesitis, and looks at the skin and nails. Blood tests and sometimes scans (X-ray, ultrasound or MRI) help build the picture.
Together you agree a treatment plan, tailored to which features are causing the most trouble. This might start with NSAIDs or a local injection for limited disease, or a DMARD such as methotrexate for persistent joint disease, with skin treatment coordinated where needed.
You are reviewed regularly. Your team checks how active the arthritis and skin are, how you are tolerating treatment, and your monitoring blood tests, and adjusts the plan, stepping up to biologics or targeted medicines if simpler treatment is not enough. There is usually a defined time to judge whether a treatment is working, and a way to contact the team about flares between appointments.
Is this treatment right for me?
A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.
May not be suitable if…
- A particular medicine may not suit you because of liver, kidney, bowel or blood problems, or a current infection.
- Some medicines are not suitable in pregnancy, breastfeeding or when planning a family.
- Strong immune-dampening treatment may be the wrong choice if disease activity is genuinely low.
- If symptoms are not due to active psoriatic arthritis, a different diagnosis or specialty may be needed.
- Certain agents are avoided if you have conditions such as inflammatory bowel disease that they could worsen.
Delay or rearrange if…
- You currently have an infection or are on antibiotics, before starting or escalating immune-dampening treatment.
- Your baseline blood tests or screening are incomplete.
- You are due, or have just had, a live vaccine.
- You could be pregnant, or are planning pregnancy, and medicines have not been reviewed.
- You have an operation planned, so medicine timing can be coordinated.
Alternatives to discuss
- NSAIDs or local steroid injections for limited or milder disease.
- Different DMARDs or combinations if the first choice does not suit or work.
- Biologic or targeted medicines (anti-TNF, IL-17, IL-23, JAK inhibitors, apremilast) if DMARDs are not enough.
- Physiotherapy, exercise, weight management and skin care alongside medicines.
- Coordinated dermatology treatment when the skin is the main problem.
Before you decide
Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.
What matters most to me?
Think about symptoms, daily life, work, caring responsibilities, sport, fertility, travel, appearance and anxiety — the right choice depends on your priorities, not just the medical facts.
What are all my options?
Ask about waiting, monitoring, medicines, rehabilitation, a smaller or larger procedure, a different test, NHS referral, or a second opinion where that would help.
What would make me pause?
Active infection, pregnancy, unstable medical problems, smoking, medicines that increase bleeding, poor support at home, or feeling pressured are all reasons to slow down and get tailored advice.
What happens if I do nothing today?
For some problems, waiting is safe; for others, delay can make treatment harder. A good consultation should explain the trade-off in plain English.
Benefits
- Can reduce joint pain, swelling and stiffness, and settle swollen fingers, toes and tendons
- Can slow or prevent joint damage and protect long-term function
- Some treatments improve the skin psoriasis as well as the joints
- Can improve fatigue, mobility and ability to work and stay active
- Provides ongoing monitoring so flares and problems are picked up
- Supports the whole person, including skin, work and wellbeing
Risks & complications
- Side effects from medicines, such as nausea or tiredness with methotrexate
- A higher chance of infections, because many PsA medicines dampen the immune system
- The need for regular monitoring blood tests
- Flares, where joints, tendons or skin worsen for a time
- Liver, blood-count or kidney changes shown on monitoring blood tests
- More serious infections needing antibiotics or hospital care
- Needing to switch medicines because one does not control the disease or is not tolerated
- Skin or gut symptoms changing with certain medicines
- Lung inflammation with methotrexate
- Reactivation of a hidden infection such as tuberculosis or hepatitis with some treatments
- Serious medicine reactions specific to the drug used
- Worsening of certain conditions (such as inflammatory bowel disease) with some agents, which guides drug choice
The main trade-offs are between controlling inflammation and the monitoring and infection risks of the medicines that do this. Because PsA can affect the joints, skin and gut, the choice of medicine is sometimes guided by which of these is most active and by other conditions you have. Poorly controlled PsA can also damage joints, so doing nothing is rarely the safer option. Ask your team how each medicine is monitored, what to do during infections, and how the skin and joints will be managed together.
Published figures to discuss
How well treatment works, and how likely side effects are, varies with the individual, the medicines used, which features are active (joints, tendons, skin) and other conditions such as bowel disease. Joints and skin can respond differently, and treatments may need switching. Because of this variation, outcomes and risks should be discussed as cautious, individual estimates rather than fixed figures.
| Figure | Reported range | How to interpret it | Source / confidence |
|---|---|---|---|
| Psoriasis patients who develop psoriatic arthritis | Often estimated at around 20 to 30%, depending on population and case definition | Joint pain, swollen fingers or toes, heel pain, nail pitting or morning stiffness in psoriasis should prompt assessment. | NHS — Psoriatic arthritisnhs.ukPublished figure |
| Joint damage if active psoriatic arthritis is untreated | Can occur early in a significant minority | Disease-modifying treatment is used to protect joints, not simply to reduce pain. | Guide sourcesClinical context |
| Uveitis or inflammatory bowel disease alongside psoriatic arthritis | Uncommon but important | These associated conditions affect biologic choice, so eye pain, light sensitivity or chronic bowel symptoms should be disclosed. | Guide sourcesClinical context |
| Cardiovascular risk in psoriatic disease | Higher than average, especially with severe skin disease or active arthritis | Blood pressure, cholesterol, smoking and weight are part of proper psoriatic arthritis care. | NHS — Psoriatic arthritisnhs.ukSource-linked context |
These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.
What happens afterwards
This is ongoing care rather than a procedure with a recovery period. What matters is how your joint, tendon and skin symptoms change over weeks to months, and how the plan is reviewed and adjusted against agreed targets.
- A gradual rather than sudden improvement over weeks
- Some good days and worse days, especially early on or during a flare
- Mild medicine side effects that often settle, such as nausea with methotrexate
- Needing regular blood tests as a routine part of treatment
- Skin and joints sometimes improving at different rates
Aftercare
- Take medicines exactly as prescribed; methotrexate, for example, is taken once a week, not daily.
- Keep up your monitoring blood tests, as several PsA medicines need regular checks.
- Watch for signs of infection and seek advice promptly; some medicines should be paused during infections.
- Avoid live vaccines unless your team agrees, and have flu and recommended COVID-19 vaccines.
- Keep treating the skin psoriasis as advised, and tell your team if the skin or joints change.
- Keep moving with suitable exercise, and use physiotherapy and other support as offered.
- Tell other clinicians, dentists and surgeons what PsA medicines you take.
- A clear, written treatment and flare plan
- Monitoring blood tests booked and a way to see the results
- Vaccinations reviewed (live vaccines avoided; flu/COVID arranged)
- Skin-care or dermatology plan in place if the skin is involved
- A named contact route for flares, infections and questions
- A list of your current medicines, including how and when to take them
- Goals noted for work, activity and, if relevant, family planning
⚠ Get urgent help if…
- A high temperature, shaking chills or feeling very unwell (possible serious infection)
- A new, very hot, swollen, painful joint, which needs urgent assessment to rule out joint infection
- Breathlessness or a new troublesome cough, especially on methotrexate (possible lung problem)
- Yellowing of the skin or eyes, very dark urine or unusual tiredness (possible liver problem)
- Unusual bruising, bleeding or a persistent sore throat (possible low blood counts)
- A painful red eye or sudden change in vision (possible eye inflammation linked to PsA)
- A widespread or rapidly worsening skin rash or pustules
Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.
General guidance — it doesn't replace the specific advice your specialist gives you.
Results & realistic expectations
A good result is psoriatic arthritis that is well controlled: fewer swollen and tender joints, settled dactylitis and enthesitis, calmer skin and nails, less fatigue and better function. This is judged over weeks to months against agreed targets and reviewed regularly, not from a single appointment.
Good control protects joints and quality of life, but it is not a cure. PsA can still flare, treatments may need switching, and monitoring continues even when you feel well. Because joints and skin can respond differently, success is judged across both, and finding the right treatment can take some adjustment.
Psoriatic arthritis is a long-term condition, so management continues over the long term, including through periods when you feel well. Many people stay on the same plan for years, while others need their medicines changed as the disease or side effects change. If disease is well controlled for a long time, treatment may sometimes be carefully reduced under specialist guidance, but it is often continued because symptoms can return. The plan is reviewed over time rather than fixed.
Related tests, treatments or support
PsA care is usually a combination: a disease-modifying or biologic medicine, NSAIDs or local injections for symptoms, skin treatment for the psoriasis, and support such as physiotherapy. Because the skin and joints are linked, rheumatology and dermatology teams often work together, and a single medicine sometimes helps both. Your team coordinates these so they work together safely, including around vaccinations, infections and operations.
Follow-up & long-term care
Follow-up is regular and ongoing: reviews of joint and skin activity, monitoring blood tests, and checks for side effects and infections, with a defined point to judge whether each treatment is working. You should be able to contact your team between appointments about flares, reactions or warning signs. Care may be shared between rheumatology, dermatology and your GP, with clear arrangements for who does what.
- Keep taking medicines as prescribed and attend monitoring blood tests.
- Keep treating the skin and tell your team if skin or joints change.
- Stay physically active and use rehabilitation support as offered.
- Keep vaccinations up to date, avoiding live vaccines where needed.
- Follow your flare plan and contact the team early when symptoms worsen.
- Review treatment regularly so it can be stepped up or carefully down.
Repeat, follow-on and what comes next
- Treatments are judged at a set point, and switched if there has not been an adequate response.
- It is common to adjust, switch or combine medicines to control both joints and skin.
- Flares may need extra short-term treatment and a review of the longer-term plan.
- Treatment may be carefully reduced if disease is well controlled for a long time, but is restarted if symptoms return.
Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.
What good aftercare looks like
- Regular review of joint and skin activity against a clear target.
- Reliable monitoring blood tests with results acted on.
- A written flare plan and a named contact route.
- Coordinated rheumatology and dermatology care where the skin is involved.
- Vaccination and infection advice, and support with exercise, work and wellbeing.
What affects the cost
Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:
- The rheumatology consultation fee and the length and number of appointments
- Blood tests and any X-rays, ultrasound or MRI scans
- The medicines used, which range from inexpensive DMARDs to costly biologics and targeted tablets
- Ongoing monitoring blood tests and review appointments
- Steroid or local injections if needed
- Skin treatment or dermatology input if the skin is involved
- Physiotherapy or other support if arranged privately
- The consultation fee and what each appointment includes
- Which tests and scans are included, and which are extra
- The cost of the proposed medicines and who prescribes and monitors them
- How often reviews and monitoring blood tests will be needed
- Whether skin treatment, injections or physiotherapy are included
- What happens, and what it costs, during a flare or if a medicine must be switched
- How rheumatology, dermatology and any NHS care will be coordinated
On the NHS? Psoriatic arthritis is diagnosed and managed on the NHS, including specialist review, medicines and monitoring; private care is mostly used for speed, choice of specialist or convenience rather than different treatment.
You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.
Consent traps and marketing red flags
These are not small details. They are often where patients lose choice, time to reflect, or realistic expectations.
Consent traps
- Treating the joints while ignoring the skin, or the other way round.
- Relying on painkillers alone without disease-modifying treatment to protect joints.
- Starting immune-dampening medicines without explaining monitoring and infection risk.
- Not discussing pregnancy plans before choosing a medicine.
- No clear flare plan, contact route or vaccination advice.
Marketing red flags
- Claims to 'cure' psoriatic arthritis or clear the skin permanently.
- Promoting a single medicine, diet or supplement as a complete answer.
- Downplaying the need for monitoring or the risk of infections.
- Escalating to expensive treatment without assessing disease activity or coordinating skin care.
Choosing a specialist safely
- Check the specialist is on the GMC Specialist Register for this area.
- Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
- You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
- Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
- You're entitled to your total cost in writing — including any follow-up — before you decide.
Questions to ask your medical professional
Take this to your consultation. A good specialist will welcome every one of these.
- Which of my problems, joints, tendons, skin or nails, are we treating first?
- Which medicine are you suggesting, and why this one for me?
- How will my skin and joints be managed together?
- What monitoring will I need, and how often?
- What is my flare plan, and who do I contact when symptoms worsen?
- What should I do with my medicines if I get an infection or need an operation?
- How does treatment fit with any plans for pregnancy or breastfeeding?
- Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
- Will you be the specialist who carries out my treatment, and who looks after me afterwards?
- What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
- What does a realistic result look like — and what can this treatment not achieve?
- What are my options, including waiting, doing nothing for now, or choosing a different approach?
- Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
- What is the total cost in writing, including any follow-ups, and how much time do I have to decide?
Frequently asked questions
Can psoriatic arthritis be cured?
Is psoriatic arthritis care free on the NHS?
Do I need to treat my skin as well as my joints?
Why do I need regular blood tests?
How soon will treatment work?
Can I get pregnant on PsA medicines?
Find a verified specialist for psoriatic arthritis treatment and management
Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.
No verified consultants list this procedure yet — browse the full directory.
How we made this page
Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →
Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.
Sources & standards: NHS — Psoriatic arthritis Versus Arthritis — Psoriatic arthritis NICE — Psoriatic arthritis (treatment technology appraisals) British Society for Rheumatology — Guidelines British Association of Dermatologists — Psoriasis
Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.
Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.
Related guides: Rheumatoid arthritis treatment and management · Disease-modifying drugs (DMARDs) · Biologic drip service (infused biologic medicines) · Ankylosing spondylitis / axial SpA treatment and management · Fibromyalgia treatment